Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Giganti, Ph.D.

Concepts (172)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections322024175360.720 Why?
Antiretroviral Therapy, Highly Active12202419000.670 Why?
Anti-HIV Agents18202445620.660 Why?
Anti-Retroviral Agents6202217870.620 Why?
Epidemiologic Research Design120193680.530 Why?
Zambia1620122750.480 Why?
Statistics as Topic1202023510.460 Why?
Biostatistics120151620.430 Why?
Epidemiologic Methods2201513260.360 Why?
Hemoglobins2201215310.280 Why?
RNA, Viral6202328670.270 Why?
Pregnancy Complications, Infectious6202421840.260 Why?
Infectious Disease Transmission, Vertical5201313540.250 Why?
Viral Load4202433850.240 Why?
Zidovudine320246250.220 Why?
Anemia1201215140.210 Why?
Latin America420174160.200 Why?
CD4 Lymphocyte Count9201725860.200 Why?
Antibodies, Viral4202432120.180 Why?
Nevirapine220102730.160 Why?
Observation120193100.150 Why?
Adult3620242233070.150 Why?
Caribbean Region220151930.150 Why?
Stillbirth220113810.150 Why?
Public Health1201026810.140 Why?
Hospitalization32024108230.130 Why?
Adenine220119930.120 Why?
Antibodies, Monoclonal4202492440.120 Why?
Antiviral Agents5202430700.110 Why?
Cohort Studies112020417100.110 Why?
Malnutrition220106290.110 Why?
HIV-15201769480.110 Why?
Humans4820247667660.110 Why?
Premature Birth1202418300.100 Why?
Female3720243965200.090 Why?
Pregnancy122024302370.090 Why?
Developing Countries2201329130.090 Why?
Continuity of Patient Care1201710770.080 Why?
Infant Mortality220137510.080 Why?
Male2720243641420.080 Why?
Fetal Death120114340.080 Why?
Acquired Immunodeficiency Syndrome1201822050.080 Why?
Contraceptives, Oral, Hormonal120091870.080 Why?
Safety1201211570.070 Why?
Child Health Services120136450.070 Why?
Treatment Outcome112024652730.070 Why?
Young Adult102024599390.070 Why?
Prenatal Care2201111580.070 Why?
Health Knowledge, Attitudes, Practice2201240560.070 Why?
Software1202044660.070 Why?
Health Education1201210600.060 Why?
Africa320137260.060 Why?
Age Distribution1201028690.060 Why?
Proportional Hazards Models62016125340.060 Why?
Inflammation12024108600.060 Why?
Antibodies, Neutralizing2202420100.050 Why?
Adolescent92017889040.050 Why?
RNA2202327150.050 Why?
Middle Aged1320242232570.050 Why?
Survival Analysis22012101000.050 Why?
Infant, Newborn62013263890.050 Why?
Half-Life120236480.050 Why?
Child, Preschool62022425770.050 Why?
Urban Population1201020400.050 Why?
Respiratory Tract Infections1200910080.050 Why?
Data Collection1201033210.040 Why?
Honduras12020390.040 Why?
Biological Assay120236260.040 Why?
Cause of Death1201137160.040 Why?
Rural Population1201123210.040 Why?
Pregnancy Outcome1201129710.040 Why?
Infant62013364610.040 Why?
Weight Gain1201023560.040 Why?
Argentina120202490.040 Why?
Chile120202580.040 Why?
Models, Biological2201394610.040 Why?
Drug Therapy, Combination2202463070.040 Why?
Drug Resistance, Viral120248680.040 Why?
Double-Blind Method22023124300.040 Why?
Retrospective Studies102022816350.040 Why?
Cross-Sectional Studies42017263100.040 Why?
Child72022806680.040 Why?
Drug Combinations1202420850.040 Why?
Urban Health220115320.040 Why?
Viremia120217270.040 Why?
Mexico120207700.040 Why?
CD4-Positive T-Lymphocytes1200944100.030 Why?
Outpatients1202415960.030 Why?
Pneumonia, Pneumocystis120182410.030 Why?
Sex Characteristics1200626450.030 Why?
Brazil1202012490.030 Why?
South America120161800.030 Why?
Kinetics1202362870.030 Why?
Phosphoproteins1202424480.030 Why?
Time Factors42023401490.030 Why?
Aging2202087310.030 Why?
Program Evaluation2201325040.030 Why?
Aged520241713430.030 Why?
Primary Health Care1201047350.030 Why?
Electronic Health Records1201148800.030 Why?
Age Factors32018183970.030 Why?
Grenada1201230.030 Why?
Drowning12012270.030 Why?
Disease Progression12009136400.030 Why?
North America1201612870.020 Why?
Algorithms12013140720.020 Why?
Gestational Age2201136170.020 Why?
Predictive Value of Tests32013154160.020 Why?
Liver Diseases1202013030.020 Why?
Immunoglobulin G1202345590.020 Why?
Canada1201621260.020 Why?
Lymphoma, Non-Hodgkin1201813740.020 Why?
Faculty120123830.020 Why?
Multivariate Analysis22013120640.020 Why?
Area Under Curve1201316380.020 Why?
Perinatal Care120112440.020 Why?
Syphilis120112430.020 Why?
Family Characteristics1201310020.020 Why?
Asia120096290.020 Why?
Early Diagnosis1201311860.020 Why?
Maternal Health Services120134730.020 Why?
Follow-Up Studies22022393090.020 Why?
Autopsy1201110110.020 Why?
Primates120095190.020 Why?
Risk Factors52013748810.020 Why?
Reverse Transcriptase Inhibitors120106180.020 Why?
Drugs, Generic120124570.020 Why?
Odds Ratio2201196610.020 Why?
Logistic Models22011132780.020 Why?
DNA, Viral1201322010.020 Why?
Case-Control Studies12024222480.020 Why?
Water1201214170.020 Why?
Renal Insufficiency, Chronic1202023060.020 Why?
HIV1201315880.020 Why?
Health Care Surveys1201324250.020 Why?
Randomized Controlled Trials as Topic12023103840.020 Why?
Health Status Indicators120119680.020 Why?
Health Services Research1201318110.020 Why?
Seroepidemiologic Studies120064040.020 Why?
Tuberculosis1201820110.010 Why?
Analysis of Variance1201362140.010 Why?
Medical Records1200914080.010 Why?
Treatment Failure1201026590.010 Why?
Educational Status1201125100.010 Why?
Polymerase Chain Reaction1201360660.010 Why?
Schools1201214950.010 Why?
Fetal Blood1201013670.010 Why?
Quality Indicators, Health Care1201318040.010 Why?
Prevalence12020158350.010 Why?
Birth Weight1201121230.010 Why?
Disease-Free Survival1201368500.010 Why?
Mothers1201322080.010 Why?
Drug Administration Schedule1201048530.010 Why?
Regression Analysis1201163290.010 Why?
Diabetes Mellitus1202058870.010 Why?
Mental Disorders1202068690.010 Why?
India1200623350.010 Why?
Feasibility Studies1201153060.010 Why?
Population Surveillance1201025940.010 Why?
Cost-Benefit Analysis1201255360.010 Why?
Socioeconomic Factors1201378410.010 Why?
Research Design1201362070.010 Why?
Health Services Accessibility1201355140.010 Why?
Mass Screening1201154540.010 Why?
Delivery of Health Care1201253680.010 Why?
Reproducibility of Results12013201440.010 Why?
Cardiovascular Diseases12020156570.010 Why?
Body Mass Index12010130500.010 Why?
Prognosis12013299480.010 Why?
Neoplasms12020223500.010 Why?
United States12016729510.000 Why?
Animals120091689300.000 Why?
Giganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (172)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.